Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Total Liabilities (2017 - 2022)

Historic Total Liabilities for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $39.0 million.

  • Iterum Therapeutics' Total Liabilities fell 1515.64% to $39.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $39.0 million, marking a year-over-year decrease of 1515.64%. This contributed to the annual value of $41.3 million for FY2021, which is 5048.05% down from last year.
  • Iterum Therapeutics' Total Liabilities amounted to $39.0 million in Q3 2022, which was down 1515.64% from $32.8 million recorded in Q2 2022.
  • In the past 5 years, Iterum Therapeutics' Total Liabilities ranged from a high of $84.1 million in Q1 2020 and a low of $22.8 million during Q3 2018
  • Its 5-year average for Total Liabilities is $51.8 million, with a median of $46.3 million in 2019.
  • Per our database at Business Quant, Iterum Therapeutics' Total Liabilities skyrocketed by 26426.59% in 2018 and then crashed by 5764.63% in 2022.
  • Quarter analysis of 5 years shows Iterum Therapeutics' Total Liabilities stood at $26.2 million in 2018, then surged by 98.06% to $52.0 million in 2019, then surged by 60.32% to $83.4 million in 2020, then tumbled by 50.48% to $41.3 million in 2021, then decreased by 5.5% to $39.0 million in 2022.
  • Its Total Liabilities stands at $39.0 million for Q3 2022, versus $32.8 million for Q2 2022 and $35.4 million for Q1 2022.